EIM
MDCO

Essex Investment Management’s Medicines Co MDCO Stock Holding History

Essex Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,894
Closed -$434K – 364
2016
Q2 		$434K Hold
12,894
– – 0.07% 252
2016
Q1 		$410K Buy
+12,894
New +$421K 0.07% 252

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Essex Investment Management's MDCO Position: Q3 2016 in Review

Essex Investment Management sold out of Medicines Co (MDCO) in Q3 2016, closing a stake of 12,894 shares — an estimated $434K sold.

Essex Investment Management first reported a position in MDCO in Q1 2016 and held it in 2 quarters. The position peaked at $434K in Q2 2016. 201 funds tracked by Wall St. Rank hold MDCO as of Q3 2016.

  • Essex Investment Management reported no remaining Medicines Co position as of Q3 2016 after selling out during the quarter.
  • Essex Investment Management sold 12,894 Medicines Co shares in Q3 2016, an estimated $434K.
  • Essex Investment Management first reported a position in Medicines Co in Q1 2016 and held it in 2 quarters.
  • Essex Investment Management's Medicines Co position peaked at $434K in Q2 2016.
  • 201 funds tracked by Wall St. Rank held Medicines Co as of Q3 2016.

Based on Essex Investment Management's 13F filing for Q3 2016, filed 1 Nov 2016.